Looks like you clickedhttps://www.globenewswire.com/news-release/2022/03/23/2408996/0/en/Novartis-Pluvicto-approved-by-FDA-as-first-targeted-radioligand-therapy-for-treatment-of-progressive-PSMA-positive-metastatic-castration-resistant-prostate-cancer.html
If you do not want to visit that page, you can close this browser tab.
